You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

January 5, 2026

Vietnam Issues Guidelines on Classification of Medical Devices for Procurement

On December 31, 2025, Vietnam’s Ministry of Health (MOH) issued Circular No. 57/2025/TT-BYT providing guidance on the classification of medical devices according to technical standards and quality requirements (Circular 57), applicable to procurement activities for medical devices in Vietnam.

According to the MOH, the purpose of the classification is to establish a principle-based legal framework and regulations that enable purchasers to easily identify groups of medical devices aligned with their professional requirements and financial capacity.

Some of the key stipulations of Circular 57 are outlined below.

Basis for Determining Technical Standards and Quality

Under Circular 57, the technical standards of medical devices are determined in accordance with Vietnamese laws on standards and technical regulations, through the following means:

  • Certification of conformity with standards in accordance with Vietnamese laws on standards and technical regulations;
  • Results of conformity assessment conducted by an internationally recognized conformity assessment organization or a legally established domestic or foreign conformity assessment organization operating in Vietnam; and
  • Documentation evidencing compliance provided by the medical device owner.

The quality of medical devices is determined based on whether the device has been approved for circulation by the relevant marketing authority of one or more jurisdictions.

Classification of Medical Devices

Circular 57 classifies medical devices into six groups (from Group 1 to Group 6) based on technical standards and quality.

Medical devices subject to classification must simultaneously meet technical standards and quality requirements in accordance with professional specifications and user needs, and must be lawfully marketed in Vietnam.

Medical devices manufactured in Vietnam may participate in all corresponding groups, provided they meet the technical standards required by the user and are lawfully marketed in Vietnam.

Outlook

Circular No. 57 will take effect on February 15, 2026, while the classification requirements will become effective on January 1, 2027.

Holders of medical device registration numbers are advised to proactively prepare documentation demonstrating compliance with technical standards and quality requirements to facilitate the classification process.

RELATED INSIGHTS​ 

July 8, 2014
The Thai Food and Drug Administration (Thai FDA) has recently amended its food product registration and controlling procedures to shorten its approval timelines, without compromising food quality or safety surveillance. This initiative has been dubbed the “Reprocessing Program.”
May 5, 2014
While Vietnam represents a huge potential market for foreign investors in the pharmaceutical industry, the sector is heavily regulated and clear guidelines are not always available. To guide pharmaceutical clients in setting up a business, marketing products, and protecting their drugs from infringement in Vietnam, Tilleke & Gibbins’ commercial and patent experts have created an informational leaflet including the following contents:
April 9, 2014
The latest edition of Practical Law Company’s Life Sciences Multi-jurisdictional Guide has been published. The guide, presented to readers in a Q&A format, provides country-specific analysis of the current regulatory framework surrounding the life sciences industry. The Thailand chapter of this guide, written by Tilleke & Gibbins, looks at the critical legal issues surrounding such topics as national healthcare, manufacturing, marketing, pricing, intellectual property, and product liability law, among others. The chapter covers the following main subjects: